While the clinical side of our department aims at a high level of treatment and care along the whole spectrum of Rheumatology, our research focuses on following diseases:
- Inflammatory autoimmune diseases (systemic sclerosis and myositides)
- Chronic arthritides (rheumatoid arthritis, spondylarthritis)
- Musculoskeletal pain syndrome (chronic back pain and complex regional pain syndrome)
The main research targets are always translational, therefore the same targets appear in clinical research as well as in molecular biology reseach programs. Generally, national and international registers exist for the main targeted diseases. These registers are of great importance for the clinical and the pre-clinical translational research.
Our research groups have been distinguished as “Center of Excellence” by the European League Against Rheumatism (EULAR).
At the moment we have 9 research groups under the leadership of Prof. Dr. Oliver Distler. The principal investigator of each group is a scientifically independent and, as a rule, habilitated scientist. Three of our groups have a clinical focus, while the other six are of a molecular biology / translational nature.